Share This Article:

Liver Transplantation in the Elderly: An Evidence Based Review on Patient Outcome, Selection and Management Strategies

Abstract Full-Text HTML Download Download as PDF (Size:992KB) PP. 651-661
DOI: 10.4236/jbise.2014.79065    2,688 Downloads   3,394 Views   Citations

ABSTRACT

There has been a steady increase in the age of potential recipients for liver transplantation over the past two decades. While patients older than age 60, on average, did not do as well as younger patients after transplantation, optimizing patient selection could minimize this discrepancy. It is appropriate to evaluate functional elderly patients without significant medical comorbidities for liver transplantation for the same indications as younger patients. For elderly patients with hepa-tocellular carcinoma and otherwise compensated liver disease, however, it is important to consider alternative treatment modalities that could provide similar survival. Elderly candidates who became too ill should be compassionately counseled away from transplantation based on existing prognostic models that can accurately predict post-transplant mortality. Finally, elderly transplant candidates and recipients may benefit from a more tailored management strategy in terms of donor risk matching and less immunosuppression.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Yu, L. and Carithers, R. (2014) Liver Transplantation in the Elderly: An Evidence Based Review on Patient Outcome, Selection and Management Strategies. Journal of Biomedical Science and Engineering, 7, 651-661. doi: 10.4236/jbise.2014.79065.

References

[1] Murray, K.F. and Carithers Jr., R.L. (2005) AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation. Hepatology, 41, 1407-1432.
http://dx.doi.org/10.1002/hep.20704
[2] UNOS (2010) United Network for Organ Sharing.
http://www.unos.org
[3] Perkins, J.D. (2012) Treatment of an Elderly Patient with Hepatocellular Carcinoma: Counseling from the Patient’s Point of View. Liver Transplantation, 18, 391-394.
http://dx.doi.org/10.1002/lt.23417
[4] Schwartz, J.J., Pappas, L., Thiesset, H.F., Vargas, G., Sorensen, J.B., Kim, R.D., Hutson, W.R., Boucher, K. and Box, T. (2012) Liver Transplantation in Septuagenarians Receiving Model for End-Stage Liver Disease Exception Points for Hepatocellular Carcinoma: The National Experience. Liver Transplantation, 18, 423-433.
http://dx.doi.org/10.1002/lt.23385
[5] Starzl, T.E., et al. (1987) Liver Transplantation in Older Patients. New England Journal of Medicine, 316, 484-485.
http://dx.doi.org/10.1056/NEJM198702193160814
[6] Aduen, J.F., Sujay, B., Dickson, R.C., Heckman, M.G., Hewitt, W.R., Stapelfeldt, W.H., Steers, J.L., Harnois, D.M. and Kramer, D.J. (2009) Outcomes after Liver Transplant in Patients Aged 70 Years or Older Compared with Those Younger Than 60 Years. Mayo Clinic Proceedings, 84, 973-978.
http://dx.doi.org/10.1016/S0025-6196(11)60667-8
[7] Rudich, S. and Busuttil, R. (1999) Similar Outcomes, Morbidity, and Mortality for Orthotopic Liver Transplantation between the Very Elderly and the Young. Transplantation Proceedings, 31, 523-552.
http://dx.doi.org/10.1016/S0041-1345(98)01537-1
[8] Schwartz, J.J., Thiesset, H., Box, T., Hutson, W. and Sorensen, J. (2012) Liver Transplantation in Septuagenarians Receiving Meld Exception Points for Hepatocellular Carcinoma: The National Experience. Liver Transplantation, 18, 1395-1396. http://dx.doi.org/10.1002/lt.23513
[9] Lipshutz, G.S., Hiatt, J., Ghobrial, R.M., Farmer, D.G., Martinez, M.M., Yersiz, H., Gornbein, J. and Busutti, R.W. (2007) Outcome of Liver Transplantation in Septuagenarians: A Single-Center Experience. Archives of Surgery, 142, 775-784.
http://dx.doi.org/10.1001/archsurg.142.8.775
[10] Bjøro, K., Höckerstedt, K., Ericzon, B.G., Friman, S., Hjortrup, A., Keiding, S., Schrumpf, E., Duraj, F., Olausson, M., Mäkisalo, H., Bergan, A. and Kirkegaard, P. (2000) Liver Transplantation in Patients over 60 Years of Age. Transplant International, 13, S165-170.
http://dx.doi.org/10.1111/j.1432-2277.2000.tb02012.x
[11] Herrero, J.I., Lucena, J.F., Quiroga, J., Sangro, B., Pardo, F., Rotellar, F., Alvárez-Cienfuegos, J. and Prieto, J. (2003) Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy. American Journal of Transplantation, 3, 1407-1412.
http://dx.doi.org/10.1046/j.1600-6143.2003.00227.x
[12] Bromley, P.N., et al. (1994) Orthotopic Liver Transplantation in Patients over 60 Years Old. Transplantation, 58, 800-803.
http://dx.doi.org/10.1097/00007890-199410000-00009
[13] Collins, B.H., et al. (2000) Long-Term Results of Liver Transplantation in Older Patients 60 Years of Age and Older. Transplantation, 70, 780-783.
http://dx.doi.org/10.1097/00007890-200009150-00012
[14] Cross, T.J., Antoniades, C.G., Muiesan, P., Al-Chalabi, T., Aluvihare, V., Agarwal, K., Portmann, B.C., Rela, M., Heaton, N.D., O’Grady, J.G. and Heneghan, M.A. (2007) Liver Transplantation in Patients over 60 and 65 Years: An Evaluation of Long-Term Outcomes and Survival. Liver Transplantation, 13, 1382-1388.
http://dx.doi.org/10.1002/lt.21181
[15] Emre, S., et al. (1993) Liver Transplantation in Patients beyond Age 60. Transplantation Proceedings, 25, 1075-1076.
[16] Filipponi, F., Roncella, M., Boggi, U., Pietrabissa, A., Romagnoli, J., Urbani, L., Biancofiore, G. and Mosca, F. (2001) Liver Transplantation in Recipients over 60. Transplantation Proceedings, 33, 1465-1466.
http://dx.doi.org/10.1016/S0041-1345(00)02552-5
[17] Garcia, C.E., Garcia, R.F.L., Mayer, A.D. and Neuberger, J. (2001) Liver Transplantation in Patients over Sixty Years of Age. Transplantation, 72, 679-684.
http://dx.doi.org/10.1097/00007890-200108270-00021
[18] Levy, M.F., Somasundar, P.S., Jennings, L.W., Jung, G.J., Molmenti, E.P., Fasola, C.G., et al. (2001) The Elderly Liver Transplant Recipient: A Call for Caution. Annals of Surgery, 233, 107-113.
http://dx.doi.org/10.1097/00000658-200101000-00016
[19] Pirsch, J.D., Kalayoglu, M., D’Alessandro, A.M., Voss, B.J., Armbrust, M.J., Reed, A., Knechtle, S.J., Sollinger, H.W. and Belzer, F.O. (1991) Orthotopic Liver Transplantation in Patients 60 Years of Age and Older. Transplantation, 51, 431-433.
http://dx.doi.org/10.1097/00007890-199102000-00031
[20] Stieber, A.C., Gordon, R.D., Todo, S., Tzakis, A.G., Fung, J.J., Casavilla, A., Selby, R.R., Mieles, L., Reyes, J. and Starzl, T.E. (1991) Liver Transplantation in Patients over Sixty Years of Age. Transplantation, 51, 271-273.
http://dx.doi.org/10.1097/00007890-199101000-00046
[21] Zetterman, R.K., Belle, S.H., Hoofnagle, J.H., Lawlor, S., Wei, Y.L., Everhart, J., Wiesner, R.H. and Lake, J.R. (1998) Age and Liver Transplantation: A Report of the Liver Transplantation Database. Transplantation, 66, 500-506.
http://dx.doi.org/10.1097/00007890-199808270-00015
[22] Yoshizumi, T., Shirabe, K., Soejima, Y., Taketomi, A., Yamashita, N., Ikegami, T., Uchiyama, H., Kayashima, H., Ninomiya, M. and Maehara, Y. (2010) Living Donor Liver Transplantation in Patients Older than 60 Years. Transplantation, 90, 433-437.
http://dx.doi.org/10.1097/TP.0b013e3181e81b2d
[23] Keswani, R.N., Ahmed, A. and Keeffe, E.B. (2004) Older Age and Liver Transplantation: A Review. Liver Transplantation, 10, 957-967.
http://dx.doi.org/10.1002/lt.20155
[24] Harrison, J., McKiernan, J. and Neuberger, J.M. (1997) A Prospective Study on the Effect of Recipient Nutritional Status on Outcome in Liver Transplantation. Transplant International, 10, 369-374.
http://dx.doi.org/10.1111/j.1432-2277.1997.tb00931.x
[25] Nair, S., Verma, S. and Thuluvath, P.J. (2002) Pretransplant Renal Function Predicts Survival in Patients Undergoing Orthotopic Liver Transplantation. Hepatology, 35, 1179-1185.
http://dx.doi.org/10.1053/jhep.2002.33160
[26] Odden, M.C., Coxson, P.G., Moran, A., Lightwood, J.M., Goldman, L. and Bibbins-Domingo, K. (2011) The Impact of the Aging Population on Coronary Heart Disease in the United States. American Journal of Medicine, 124, 827-833.e5.
[27] Epstein, M. (1996) Aging and the Kidney. Journal of the American Society of Nephrology, 7, 1106-1122.
[28] Looker, A.C., Melton III, L.J., Harris, T.B., Borrud, L.G. and Shepherd, J.A. (2010) Prevalence and Trends in Low Femur Bone Density among Older US Adults: NHANES 2005-2006 Compared with NHANES III. Journal of Bone and Mineral Research, 25, 64-71.
http://dx.doi.org/10.1359/jbmr.090706
[29] Yancik, R. (1997) Cancer Burden in the Aged: An Epidemiologic and Demographic Overview. Cancer, 80, 1273-1283.
http://dx.doi.org/10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4
[30] Berry, J.D., Dyer, A., Cai, X., Garside, D.B., Ning, H.y., Thomas, A., Greenland, P., Van Horn, L., Tracy, R.P. and Lloyd-Jones, D.M. (2012) Lifetime Risks of Cardiovascular Disease. New England Journal of Medicine, 366, 321-329. http://dx.doi.org/10.1056/NEJMoa1012848
[31] Lindeman, R.D., Tobin, J. and Shock, N.W. (1985) Longitudinal Studies on the Rate of Decline in Renal Function with Age. Journal of the American Geriatrics Society, 33, 278-285.
[32] Esposito, C., Plati, A., Mazzullo, T., Fasoli, G., De Mauri, A., Grosjean, F., Mangione, F., Castoldi, F., Serpieri, N., Cornacchia, F. and Dal Canton, A. (2007) Renal Function and Functional Reserve in Healthy Elderly Individuals. Journal of Nephrology, 20, 617-625.
[33] Luft, F.C., Grim, C.E., Fineberg, N. and Weinberger, M.C. (1979) Effects of Volume Expansion and Contraction in Normotensive Whites, Blacks, and Subjects of Different Ages. Circulation, 59, 643-650.
http://dx.doi.org/10.1161/01.CIR.59.4.643
[34] Coresh, J., Selvin, E., Stevens, L.A., Manzi, J., Kusek, J.W., Eggers, P., Van Lente, F. and Levey, A.S. (2007) Prevalence of Chronic Kidney Disease in the United States. JAMA, 298, 2038-2047.
http://dx.doi.org/10.1001/jama.298.17.2038
[35] Sokhi, R.P., Anantharaju, A., Kondaveeti, R., Creech, S.D., Islam, K.K. and Van Thiel, D.H. (2004) Bone Mineral Density among Cirrhotic Patients Awaiting Liver Transplantation. Liver Transplantation, 10, 648-653.
http://dx.doi.org/10.1002/lt.20104
[36] Hui, S.L., Slemenda, C.W. and Johnston Jr., C.C. (1988) Age and Bone Mass as Predictors of Fracture in a Prospective Study. Journal of Clinical Investigation, 81, 1804-1809.
http://dx.doi.org/10.1172/JCI113523
[37] Hoshida, Y., Ikeda, K., Kobayashi, M., Suzuki, Y., Tsubota, A., Saitoh, S., et al. (1999) Chronic Liver Disease in the Extremely Elderly of 80 Years or More: Clinical Characteristics, Prognosis and Patient Survival Analysis. Journal of Hepatology, 31, 860-866.
http://dx.doi.org/10.1016/S0168-8278(99)80287-6
[38] Bradley, S.M., Soine, L.A., Caldwell, J.H. and Goldberg, S.L. (2010) Screening Stress Myocardial Perfusion Imaging and Eligibility for Liver Transplantation. American Journal of Cardiology, 105, 1010-1013.
http://dx.doi.org/10.1016/j.amjcard.2009.11.023
[39] Ehtisham, J., Altieri, M., Salamé, E., Saloux, E., Ollivier, I. and Hamon, M. (2010) Coronary Artery Disease in Orthotopic Liver Transplantation: Pretransplant Assessment and Management. Liver Transplantation, 16, 550-557.
[40] Tiukinhoy-Laing, S.D., Rossi, J.S., Bayram, M., De Luca, L., Gafoor, S., Blei, A., Flamm, S., Davidson, C.J. and Gheorghiade, M. (2006) Cardiac Hemodynamic and Coronary Angiographic Characteristics of Patients Being Evaluated for Liver Transplantation. American Journal of Cardiology, 98, 178-181.
http://dx.doi.org/10.1016/j.amjcard.2006.01.089
[41] Caregaro, L., Menon, F., Angeli, P., Amodio, P., Merkel, C., Bortoluzzi, A., Alberino, F. and Gatta, A. (1994) Limitations of Serum Creatinine Level and Creatinine Clearance as Filtration Markers in Cirrhosis. JAMA Internal Medicine, 154, 201-205.
http://dx.doi.org/10.1001/archinte.1994.00420020117013
[42] Koopman, R. and van Loon, L.J. (2009) Aging, Exercise, and Muscle Protein Metabolism. Journal of Applied Physiology, 106, 2040-2048.
http://dx.doi.org/10.1152/japplphysiol.91551.2008
[43] Proulx, N.L., Akbari, A., Garg, A.X., Rostom, A., Jaffey, J. and Clark, H.D. (2005) Measured Creatinine Clearance from Timed Urine Collections Substantially Overestimates Glomerular Filtration Rate in Patients with Liver Cirrhosis: A Systematic Review and Individual Patient Meta-Analysis. Nephrology Dialysis Transplantation, 20, 1617-1622.
http://dx.doi.org/10.1093/ndt/gfh839
[44] Gerbes, A.L., Gülberg, V., Bilzer, M. and Vogeser, M. (2002) Evaluation of Serum Cystatin C Concentration as a Marker of Renal Function in Patients with Cirrhosis of the Liver. Gut, 50, 106-110.
http://dx.doi.org/10.1136/gut.50.1.106
[45] Eason, J.D., Gonwa, T.A., Davis, C.L., Sung, R.S., Gerber, D. and Bloom, R.D. (2008) Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). American Journal of Transplantation, 8, 2243-2251.
http://dx.doi.org/10.1111/j.1600-6143.2008.02416.x
[46] Toy, E., Balasubramanian, S., Selmi, C., Li, C.S. and Bowlus, C.L. (2011) The Prevalence, Incidence and Natural History of Primary Sclerosing Cholangitis in an Ethnically Diverse Population. BMC Gastroenterology, 11, 83.
http://dx.doi.org/10.1186/1471-230X-11-83
[47] Chapman, R., Fevery, J., Kalloo, A., Nagorney, D.M., Muri Boberg, K., Shneider, B. and Gores, G.J. (2010) Diagnosis and Management of Primary Sclerosing Cholangitis. Hepatology, 51, 660-678.
http://dx.doi.org/10.1002/hep.23294
[48] Asahina, Y., Tsuchiya, K., Tamaki, N., Hirayama, I., Tanaka, T., Sato, M., Yasui, Y., et al. (2010) Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection. Hepatology, 52, 518-527.
http://dx.doi.org/10.1002/hep.23691
[49] Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A. and Gennari, L. (1996) Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with cirrhosis. New England Journal of Medicine, 334, 693-699. http://dx.doi.org/10.1056/NEJM199603143341104
[50] Englesbe, M.J., Patel, S.P., He, K., Lynch, R.J., Schaubel, D.E., Harbaugh, C., Holcombe, S.A., Wang, S.C., Segev, D.L. and Sonnenday, C.J. (2010) Sarcopenia and Mortality after Liver Transplantation. Journal of the American College of Surgeons, 211, 271-278.
http://dx.doi.org/10.1016/j.jamcollsurg.2010.03.039
[51] Hasse, J., Strong, S., Gorman, M.A. and Liepa, G. (1993) Subjective Global Assessment: Alternative Nutrition-Assessment Technique for Liver-Transplant Candidates. Nutrition, 9, 339-343.
[52] Malinchoc, M., Kamath, P.S., Gordon, F.D., Peine, C.J., Rank, J. and ter Borg, P.C.J. (2000) A Model to Predict Poor Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunts. Hepatology, 31, 864-871.
http://dx.doi.org/10.1053/he.2000.5852
[53] Kamath, P.S., Wiesner, R.H., Malinchoc, M., Kremers, W., Therneau, T.M., Kosberg, C.L., D’Amico, G., Dickson, E.R. and Kim, W.R. (2001) A Model to Predict Survival in Patients with End-Stage Liver Disease. Hepatology, 33, 464-470.
http://dx.doi.org/10.1053/jhep.2001.22172
[54] Merion, R.M., Schaubel, D.E., Dykstra, D.M., Freeman, R.B., Port, F.K. and Wolfe, R.A. (2005) The Survival Benefit of Liver Transplantation. American Journal of Transplantation, 5, 307-313.
http://dx.doi.org/10.1111/j.1600-6143.2004.00703.x
[55] Aloia, T.A., Knight, R., Gaber, A.O., Ghobria, R.M. and Goss, J.A. (2010) Analysis of Liver Transplant Outcomes for United Network for Organ Sharing Recipients 60 Years Old or Older Identifies Multiple Model for End-Stage Liver Disease-Independent Prognostic Factors. Liver Transplantation, 16, 950-959.
http://dx.doi.org/10.1002/lt.22098
[56] Rana, A., Hardy, M.A., Halazun, K.J., Woodland, D.C., Ratner, L.E., Samstein, B., Guarrera, J.V., Brown Jr., R.S. and Emond, J.C. (2008) Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation. American Journal of Transplantation, 8, 2537-2546.
http://dx.doi.org/10.1111/j.1600-6143.2008.02400.x
[57] De Giorgio, M., Vezzoli, S., Cohen, E., Armellini, E., Lucà, M.G., Verga, G., Pinelli, D., Nani, R., Valsecchi, M.G., Antolini, L., Colledan, M., Fagiuoli, S. and Strazzabosco, M. (2010) Prediction of Progression-Free Survival in Patients Presenting with Hepatocellular Carcinoma within the Milan Criteria. Liver Transplantation, 16, 503-512.
[58] (1997) Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document. Hepatology, 25, 658-663.
http://dx.doi.org/10.1002/hep.510250328
[59] Henley, K.S., Lucey, M.R., Appelman, H.D., Baliga, P., Brown, K.A., Burtch, G.D., Campbell Jr., D.A., Ham, J.M., Merion, R.M. and Turcotte, J.G. (1992) Biochemical and Histopathological Correlation in Liver Transplant: The First 180 Days. Hepatology, 16, 688-693.
http://dx.doi.org/10.1002/hep.1840160312
[60] The U.S. Multicenter FK506 Liver Study Group (1994) A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation. New England Journal of Medicine, 331, 1110-1115.
http://dx.doi.org/10.1056/NEJM199410273311702
[61] Wiesner, R.H., Demetris, A.J., Belle, S.H., Seaberg, E.C., Lake, J.R., Zetterman, R.K., Everhart, J. and Detre, K.M. (1998) Acute Hepatic Allograft Rejection: Incidence, Risk Factors, and Impact on Outcome. Hepatology, 28, 638-645.
http://dx.doi.org/10.1002/hep.510280306
[62] European FK506 Multicentre Liver Study Group (1994) Randomised Trial Comparing Tacrolimus (FK506) and Cyclosporin in Prevention of Liver Allograft Rejection. Lancet, 344, 423-428.
http://dx.doi.org/10.1016/S0140-6736(94)91766-3
[63] Herrero, J.I., Lorenzo, M., Quiroga, J., Sangro, B., Pardo, F., Rotellar, F., Alvarez-Cienfuegos, J. and Prieto, J. (2005) De Novo Neoplasia after Liver Transplantation: An Analysis of Risk Factors and Influence on Survival. Liver Transplantation, 11, 89-97.
http://dx.doi.org/10.1002/lt.20319
[64] Ojo, A.O., Held, P.J., Port, F.K., Wolfe, R.A., Leichtman, A.B., Young, E.W., Arndorfer, J., Christensen, L. and Merion, R.M. (2003) Chronic Renal Failure after Transplantation of a Nonrenal Organ. New England Journal of Medicine, 349, 931-940.
http://dx.doi.org/10.1056/NEJMoa021744
[65] Gonwa, T.A., Mai, M.L., Melton, L.B., Hays, S.R., Goldstein, R.M., Levy, M.F. and Klintmalm, G.B. (2001) End-Stage Renal Disease (ESRD) after Orthotopic Liver Transplantation (OLTX) Using Calcineurin-Based Immunotherapy: Risk of Development and Treatment. Transplantation, 72, 1934-1939.
http://dx.doi.org/10.1097/00007890-200112270-00012
[66] Jain, A., Patil, V.P. and Fung, J. (2008) Incidence of de Novo Cancer and Lymphoproliferative Disorders after Liver Transplantation in Relation to Age and Duration of Follow-Up. Liver Transplantation, 14, 1406-1411.
http://dx.doi.org/10.1002/lt.21609
[67] Mackay, A.J., Angus, P.W. and Gow, P.J. (2011) Long-Term Outcomes of Calcineurin Inhibitor Withdrawal for Post-Liver Transplant Renal Dysfunction. Transplantation Proceedings, 43, 3802-3806.
http://dx.doi.org/10.1016/j.transproceed.2011.10.044

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.